Repositioning of a cyclin-dependent kinase inhibitor GW8510 as a ribonucleotide reductase M2 inhibitor to treat human colorectal cancer
Crossref DOI link: https://doi.org/10.1038/cddiscovery.2016.27
Published Online: 2016-05-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hsieh, Y-Y
Chou, C-J
Lo, H-L
Yang, P-M
Text and Data Mining valid from 2016-05-09
Version of Record valid from 2016-05-09
Article History
Received: 23 March 2016
Accepted: 3 April 2016
First Online: 9 May 2016
Competing interests
: The authors declare no conflict of interest.